Restor3d announced a strategic investment partnership with Partners Group. Under the agreement, Partners Group will acquire a minority stake in restor3d, marking the companyβs first institutional investment.
As part of this transaction, restor3d has raised a total of $104 million, including $65 million of new equity from Partners Group and $39 million from existing shareholders.
Founded in 2017, restor3d combines proprietary design software, vertically integrated additive manufacturing, and surgical planning to deliver implants tailored to both surgeon preference and patient anatomy. With FDA-cleared solutions across shoulder, hip, knee, foot, and ankle, restor3d gives surgeons with patient-specific implants that improve surgical fit and function. In 2024, the company partnered with more than 520 surgeons across 740 hospitals nationwide.
The proceeds from the investment will be used for continued product innovation, expand commercial growth, and broaden access to personalized orthopedic care. Partners Group will also join restor3dβs board of directors, contributing its deep operational experience and healthcare expertise to support the Companyβs long-term strategy.
βThis investment marks an exciting milestone for restor3d as we expand access to personalized orthopedic solutions,β said Kurt Jacobus, CEO of restor3d. βWith Partners Groupβs support, we will continue to deliver innovations that empower surgeons and improve outcomes for patients across the full spectrum of joint replacement.β
